How have TRSBF shares performed in 2024?

3SBio's stock was trading at $0.80 at the beginning of 2024. Since then, TRSBF shares have increased by 0.0% and is now trading at $0.80. View the best growth stocks for 2024 here .

Are investors shorting 3SBio?

3SBio saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 399,300 shares, a decline of 24.5% from the April 30th total of 528,800 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. View 3SBio's Short Interest .

How do I buy shares of 3SBio?

Shares of TRSBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TRSBF

3SBio (TRSBF) Stock Price, News & Analysis

→ This military-backed stock “owns” AI market (From Porter & Company) (Ad)

Free TRSBF Stock Alerts

$0.80

0.00 (0.00%)

(As of 05/12/2023)

Compare

Today's Range: $0.80
▼
$0.80
50-Day Range: $0.80
▼
$0.80
52-Week Range: $0.80
▼
$0.80

Volume: N/A
Average Volume: 63,275 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get 3SBio alerts:

Ad Priority Gold

Alert: Your Bank is Dying – Act Now or Lose Everything!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

About 3SBio

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer; TNF, pre-filled aqueous injection solution. It also offers YISAIPU, the receptor fusion tumor necrosis factor inhibitor; Mandi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium. In addition, the company provides MN709 Minoxidil Foam and Nalfuraphine hydrochloride tablets. Further, it provides trading, project management and consultation, technology, sports, financial, investment advisory, as well as manufactures medical devices; and offers agricultural services. The company has collaboration agreements with companies, such as Toray. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.

TRSBF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRSBF Stock News Headlines

July 28, 2022 | markets.businessinsider.com

Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China

August 26, 2021 | finance.yahoo.com

3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development

See More Headlines

Receive TRSBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 3SBio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:TRSBF
CUSIP: N/A
CIK: N/A
Web: www.3sbio.com
Phone: 86 24 2538 6000
Fax: N/A
Employees: 5,411
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Jing Lou M.D. (Age 61)
Ph.D., Co-Founder, Executive Chairman, CEO & President
Comp: $687.53k
Dr. Dongmei Su (Age 54)
Senior VP & Executive Director
Comp: $205.73k
Mr. Xiang He (Age 40)
Chief Financial Officer
Ms. Siu Kuen Lai FCIS (Age 48)
FCS, Company Secretary
Zhao Xinyi
Executive of IR

Key Competitors

View All Competitors

TRSBF Stock Analysis - Frequently Asked Questions

How have TRSBF shares performed in 2024?: 3SBio's stock was trading at $0.80 at the beginning of 2024. Since then, TRSBF shares have increased by 0.0% and is now trading at $0.80.
View the best growth stocks for 2024 here.
Are investors shorting 3SBio?: 3SBio saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 399,300 shares, a decline of 24.5% from the April 30th total of 528,800 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
View 3SBio's Short Interest.
How do I buy shares of 3SBio?: Shares of TRSBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TRSBF) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial